|
Boston Biomedica awarded United States patent for extraction of nucleic acids from cells using pressure cycling technology.(Brief Article)
BIOTECH Patent News
|
September 1, 2000
|
COPYRIGHT 2000 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
Boston Biomedica, Inc. (West Bridgewater, MA; 508-580-1900) announced that the United States Patent and Trademark Office has issued the company a patent covering devices for the separation and purification of nucleic acids from cells, tissue, and microbes for use with Boston Biomedica's proprietary Pressure Cycling Technology. These devices will make it possible to couple Pressure Cycling Technology extraction with adsorption-based technology for nucleic acid purification and concentration, to provide a versatile, rapid, efficient and simple Pressure Cycling Technology-based ...
Find more facts and information related to the
article "Boston Biomedica awarded United States patent for ..."